Composite surge masks QoQ momentum loss; guidance maintained
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit composite growth 25-30% guidance (delivered 29.3%). Maintained volume growth >15% and PAT guidance. Missed working capital targets; value-added mix lagging.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q1 revenue/PAT growth (25%/22% YoY) and composite momentum (29.3%) validate core business health, but QoQ PAT decline (-12.2%), working capital deterioration to 110 days (vs 90-day target), and value-added product mix stuck at 25.4% (vs 35% target) signal operational challenges beneath headline growth. Guidance MAINTAINED (not raised), and management is realistic on polymer price volatility. Suitable as a quality compounder with execution risk.
₹1694 Cr
Revenue · +25.1% YoY₹116 Cr
Reported PAT · +22.2% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
Composite products delivered 29% growth
METTranscript states 29.3% composite growth in Q1
PAT growth 22.2% reflects operational excellence
OVERSTATEDPAT growth 22.2% YoY supported by EBITDA +15%, but QoQ PAT declined -12.2%
Robust order book of ₹185 Cr in composites
METOrder book cited; coupled with ₹400 Cr packaging orders for FY27
Value-added products driving higher margins
MISSValue-added product share only 25.4% vs prior target of 35% in 2 years
Working capital managed well
MISSCycle time 110 days in Q1 vs target 90 days; deteriorated from 100 days in Dec 2025
Earnings quality
What changed since the last call
Value-added product share
DowngradeTarget 35% of sales in 2 years; currently only 25.4%. Composite order book ₹185 Cr supports growth but mix not yet achieved
Working capital cycle
DowngradeDeteriorated to 110 days from 100 days in Dec 2025 due to polymer price spike; target remains 90 days
ROCE trajectory
NeutralMaintained +1.75% annual increase plan; March 2026 was 19%, targeting 24% in 3 years (by March 2029)
Solar power cost savings
UpgradeAchieved ₹12 Cr this year; targeting ₹35 Cr if all operating states adopt green power policy
Guidance for volume/margin growth
NeutralReaffirmed >15% volume growth, 25-30% composite growth, 19-20% EBITDA growth, 23-24% PAT growth; no change
The Q&A
Analysts pressed hard on working capital deterioration, polymer price pass-through lag, PE pipe volume softness, and debt/finance cost reconciliation. Management was candid on timing issues in PE pipes and inflation hedging via monthly pricing, but deflected detailed debt reconciliation to CFO follow-up. Overall moderate pressure, no sharp skepticism; analysts seemed satisfied on composites trajectory.
Working capital & cash deployment — Kumar Saurabh, Scientific Investing
PartialWorking capital cycle at 110 days due to March polymer spike; target 90 days by year-end. On cash deployment: following board/investor guidelines; open to organic/inorganic growth if ROCE >target. Buyback and dividend payout ratio increase also under consideration from FY27 onwards.
Polymer pricing & pass-through — Karan, Guardian Capital Partners
Answered75% customers on monthly pricing (8-12th of each month). Major increases March-April fully passed on; July decreases (₹23 Cr) passed with 1-month lag. With 3-month lag, no net pricing gap. 25% other products (composites) with 6-month inventory carry fixed pricing.
PE pipe weakness & crude assumptions — Aryan, Equitas Investments
AnsweredQ1 soft due to government not passing EPC contractor cost increases; Q2-Q3 recovery expected. Reasonable crude $70-80/bbl (oil producer needs $55 profit); implies polymer $1,100-1,250. At normalized levels, EBITDA margin 14-15.5% is sustainable.
LPG cylinder domestic/export split — Rohit Suresh, Samatva Investments
AnsweredNormally 50-50 domestic/export. Within domestic: entirely PSU (HPCL, IOCL, BPCL). Non-PSU only legacy (Reliance repurposing old stock); not current supply.
Debt, finance cost, other income reconciliation — Devam, ARDEKO Asset Management
PartialCost of funds 8.5% India / 6.5% overseas. QIP proceeds in FD; interest netted off, not in other income. Other income ₹1 Cr (rental income only). Finance cost ₹35-40 Cr on non-fund-based facilities (bank guarantees, LC, documentation); not debt interest.
Guidance
FY27 volume growth >15% (maintained from prior calls)
HighComposite 25-30%, PE pipe 20-25%, packaging 11-13%, others 10-12%. Combined 15%+ growth
EBITDA growth 19-20%, PAT growth 23-24% when 15% volume achieved (FY27)
HighAssumes normalized polymer prices. Driven by automation, power cost savings (₹12-35 Cr), manpower reduction, finance cost decline
EBITDA margin target 14-15.5% at normalized polymer prices ($70-80 oil, $1,100-1,250 polymer)
MediumQ1 delivered 13.3%; depends on commodity stabilization and monthly pricing pass-through effectiveness
FY26-27 capex ₹350 Cr (consolidation phase); post-2027 normalized to ₹200-250 Cr annually
HighIncludes ₹28 Cr maintenance, ₹47 Cr value-added this Q. Automation, new capacity (Gujarat, Odisha, Chiplun, Saudi), recycling expansion
Risks the call surfaced
Commodity volatility
HighPolymer prices $600-1,800 range historically. 20-25 day pass-through lag creates margin compression risk if prices spike suddenly
Government project dependency
MediumQ1 PE pipe volumes weak due to government not passing cost increases to EPC contractors. H2 dependent on rains ending and project resumption
Working capital deterioration
MediumCycle time 110 days vs 90-day target; deteriorated from 100 days in Dec 2025 due to raw material price spikes and inventory carry
Value-added product mix lag
MediumValue-added products (composite, IBC) only 25.4% of sales; two-year target 35%. Margin expansion strategy partially behind
Geopolitical disruption
MediumOngoing geopolitical tensions affect raw material pricing, shipping costs, export demand (Ebullient 60% export to Middle East). Macro uncertainty caps guidance from price perspective
Management
Score 7/10. Detailed, technical but verbose. MD provided granular insights on pricing mechanisms, working capital calculations, polymer fundamentals. Defensive on some metrics (working capital, finance costs) but ultimately transparent. Invited deeper discussion rather than dodge. Mixed. Hit composite 25-30% guidance (29.3% delivered), volume growth on track (11% Q1 toward 15% FY27). Missed working capital targets (110 days vs 90-day goal). Value-added mix lagging (25.4% vs 35% target). Debt reduction on track (₹90 Cr this Q). PAT growth 22% vs guidance of 23-24% when 15% volume achieved—slightly short.
1 · Aug-Sep 2026
PE pipe recovery; 75% capacity utilization targeted (post-rains, Q2 focus)
2 · H2 FY27
Fire extinguisher commercial production; 800k units targeted for refinery/oil companies
3 · Sep-Oct 2026
LPG composite cylinder approvals (250-350L CNG cascade); reduce cost vs competition
Suitable as a quality compounder with execution risk.
Informational and educational content only. Not investment advice.